Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

St. John's wort.

Silvana Lawvere1, Martin C Mahoney

  • 1Department of Clinical Prevention, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

American Family Physician
|December 14, 2005
PubMed
Summary
This summary is machine-generated.

St. John's wort effectively treats mild to moderate depression, outperforming placebo and matching standard antidepressants. However, its efficacy in major depression remains uncertain, and it may interact with other medications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do lab-based assessments of pretreatment smoking reinforcement and cue-specific craving predict smoking cessation with varenicline?

Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors·2025
Same author

Cigarette smoking and chronic disease in the United States, 2021-2023.

Preventive medicine·2025
Same author

Sex-Specific Mediation of Pre-Quit Smoking Reduction: Secondary Analysis of a Randomized Controlled Trial Extending Varenicline Preloading.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2025
Same author

Daily Cigarette Abstinence and Smoking Rate With Varenicline: Relationships With Treatment, Craving, and Affect During the First Week of the Quit Attempt.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2025
Same author

Correction to: Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in waves 1 through 5 (2013-2019) of the population assessment of tobacco and health (PATH) study.

Respiratory research·2025
Same author

Evaluating mediators of the effect of varenicline preloading on smoking abstinence in a randomized controlled trial.

Addiction (Abingdon, England)·2025
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Area of Science:

  • Phytomedicine
  • Neuroscience
  • Pharmacology

Background:

  • St. John's wort (Hypericum perforatum) is a widely used herbal remedy.
  • Hypericin and hyperforin are key bioactive compounds with extensive research.
  • Standardized extracts ensure consistent content of active components.

Purpose of the Study:

  • To evaluate the efficacy of St. John's wort in treating depression.
  • To compare its effectiveness against placebo and conventional antidepressants.
  • To assess its utility in different depression severities.

Main Methods:

  • Systematic review and meta-analysis of clinical trials.
  • Analysis of studies focusing on mild to moderate depression.
  • Examination of research concerning major depression.

Related Experiment Videos

Main Results:

  • St. John's wort demonstrated superiority over placebo for mild to moderate depression.
  • It showed equivalence to standard antidepressant medications in this patient group.
  • Results for major depression were inconsistent across studies.

Conclusions:

  • St. John's wort is a viable treatment option for mild to moderate depression.
  • Further research is needed to clarify its role in major depression.
  • Potential drug interactions with St. John's wort require clinical consideration.